Department of Surgery, Division of Vascular Surgery, University of Wisconsin, Madison, WI, USA.
Crit Care Med. 2013 Jan;41(1):1-8. doi: 10.1097/CCM.0b013e31826a4650.
Evidence suggests that surgeons implicitly negotiate with their patients preoperatively about the use of life supporting treatments postoperatively as a condition for performing surgery. We sought to examine whether this surgical buy-in behavior is present among a large, nationally representative sample of surgeons who routinely perform high-risk operations.
Using findings from a qualitative study, we designed a survey to determine the prevalence of surgical buy-in and its consequences. Respondents were asked to consider their response to a patient at moderate risk for prolonged mechanical ventilation or dialysis who has a preoperative request to limit postoperative life- supporting treatment. We used bivariate and multivariate analysis to identify surgeon characteristics associated with 1) preoperatively creating an informal contract with the patient defining agreed upon limitations of postoperative life support and 2) declining to operate on such patients.
U.S. mail-based survey of 2,100 cardiothoracic, vascular, and neurosurgeons.
None.
The adjusted response rate was 56%. Nearly two thirds of respondents (62%) reported they would create an informal contract with the patient describing agreed upon limitations of aggressive therapy and a similar number (60%) endorsed sometimes or always refusing to operate on a patient with preferences to limit life support. After adjusting for potentially confounding covariates, the odds of preoperatively contracting about life-supporting treatment were more than two-fold greater among surgeons who felt it was acceptable to withdraw life support on postoperative day 14 compared with those who believed it was not acceptable to withdraw life support on postoperative day 14 (odds ratio 2.1, 95% confidence intervals 1.3-3.2).
Many surgeons will report contracting informally with patients preoperatively about the use of postoperative life support. Recognition of this process and its limitations may help to inform postoperative decision making.
有证据表明,外科医生在术前会与患者就术后使用生命支持治疗进行隐性协商,将其作为实施手术的条件。我们试图研究这种手术“买入”行为是否存在于大量、具有代表性的常规进行高风险手术的外科医生群体中。
我们利用一项定性研究的结果设计了一项调查,以确定手术“买入”的普遍性及其后果。受访者被要求考虑他们对一位中度风险需要长时间机械通气或透析的患者的反应,该患者在术前要求限制术后生命支持治疗。我们使用单变量和多变量分析来确定与 1)术前与患者建立非正式合同,定义术后生命支持的商定限制和 2)拒绝为这类患者手术相关的外科医生特征。
针对 2100 名心胸、血管和神经外科医生的美国邮件调查。
无。
调整后的回复率为 56%。近三分之二的受访者(62%)表示,他们将与患者签订一份非正式合同,描述商定的积极治疗限制,类似数量的受访者(60%)表示有时或总是拒绝为有意愿限制生命支持的患者手术。在调整了潜在的混杂因素后,与那些认为术后第 14 天不可接受撤生命支持的医生相比,认为术后第 14 天可以接受撤生命支持的医生术前关于生命支持治疗的合同的可能性是前者的两倍多(比值比 2.1,95%置信区间 1.3-3.2)。
许多外科医生将报告与患者在术前就术后使用生命支持进行非正式协商。认识到这一过程及其局限性可能有助于为术后决策提供信息。